Balaji Bhujbal

Balaji Bhujbal is an experienced biotechnology professional with a comprehensive background in various aspects of biopharmaceutical production. Currently serving as an Executive Officer at Serum Institute of India Pvt. Ltd. since February 2022, Balaji previously held positions as a Senior Executive at Reliance Life Sciences, where expertise was focused on monoclonal antibodies and erythropoietin production. Prior roles include Executive at Wockhardt Ltd., specializing in insulin manufacturing, Production Officer at Shantha Biotechnics Limited, working on tetanus toxoid vaccine production, and Jr. Executive at Unique Biotech Ltd., contributing to probiotic and enzyme production. Balaji holds an MSc in Biotechnology from Swami Ramanand Teerth Marathwada University, earned between 2008 and 2014.